Zentalis Pharmaceuticals, Inc. (ZNTL) Free cash flow 2019–2025
Zentalis Pharmaceuticals, Inc. (ZNTL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$125.2MFY2025 · since FY2019: -$39.5M → -$125.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$125.2M | +26.8% |
| FY2024 | -$171.1M | +17.9% |
| FY2023 | -$208.4M | -25.3% |
| FY2022 | -$166.3M | -3.8% |
| FY2021 | -$160.2M | -82.9% |
| FY2020 | -$87.6M | -121.8% |
| FY2019 | -$39.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice